Ovid Therapeutics Inc.

NASDAQ: OVID · Real-Time Price · USD
0.96
0.12 (14.24%)
At close: Aug 15, 2025, 3:59 PM
0.97
0.54%
After-hours: Aug 15, 2025, 07:58 PM EDT

Ovid Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
26.3M 27.04M 44.87M 187.8M
Short-Term Investments
26.77M 78.79M 84.13M n/a
Long-Term Investments
20.97M 17.63M 5.62M 1.63M
Other Long-Term Assets
1.93M 1.96M 1.97M 1.93M
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
2.87M 3.76M 2.38M n/a
Total Current Assets
55.94M 109.6M 131.38M 190.48M
Property-Plant & Equipment
13.23M 14.66M 16.07M 242.76K
Goodwill & Intangibles
92K 182.97K 222.1K 164.09K
Total Long-Term Assets
36.23M 34.43M 23.89M 4.07M
Total Assets
92.17M 144.03M 155.27M 194.54M
Account Payables
3.19M 3.7M 1.95M 7.13M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.34M 1.25M 533.95K n/a
Other Current Liabilities
-1.34M -1.25M -533.95K 3.91M
Total Current Liabilities
10.52M 11.47M 6.99M 14.8M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a 30M n/a n/a
Total Long-Term Liabilities
13.42M 44.76M 16M 7.13M
Total Liabilities
23.94M 56.23M 22.99M 14.8M
Total Debt
14.76M 16M 16.54M n/a
Common Stock
71K 70.69K 70.47K 70.36K
Retained Earnings
-304.3M -277.87M -225.53M -171.36M
Comprehensive Income
-35K 702.00 -42.19K n/a
Shareholders Equity
68.23M 87.8M 132.27M 179.75M
Total Investments
47.75M 96.42M 89.76M 1.63M